Growth Metrics

Core Laboratories (CLB) Deferred Taxes (2022 - 2026)

Core Laboratories filings provide 5 years of Deferred Taxes readings, the most recent being $3.7 million for Q1 2026.

  • On a quarterly basis, Deferred Taxes rose 104.68% to $3.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $482000.0, a 87.86% decrease, with the full-year FY2025 number at -$1.4 million, down 110.68% from a year prior.
  • Deferred Taxes hit $3.7 million in Q1 2026 for Core Laboratories, up from -$6.0 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $11.9 million in Q2 2023 to a low of -$6.0 million in Q4 2025.
  • Median Deferred Taxes over the past 5 years was $1.3 million (2025), compared with a mean of $835533.3.
  • The widest YoY moves for Deferred Taxes: up 259.95% in 2025, down 947.73% in 2025.
  • Core Laboratories' Deferred Taxes stood at -$2.2 million in 2022, then plummeted by 76.16% to -$3.9 million in 2023, then surged by 85.5% to -$572000.0 in 2024, then plummeted by 947.73% to -$6.0 million in 2025, then surged by 162.06% to $3.7 million in 2026.
  • The last three reported values for Deferred Taxes were $3.7 million (Q1 2026), -$6.0 million (Q4 2025), and $1.4 million (Q3 2025) per Business Quant data.